(Q44480350)

English

Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes: influence of prior antidiabetic drug regimen

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes: influence of prior antidiabetic drug regimen (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Marc S Rendell

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

N Bradly Glazer

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Zhan Ye

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Journal of Diabetes and its Complications

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

211-217

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900005-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900005-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900005-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900005-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900005-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900005-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1056-8727(03)00005-9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

release_nkfq2ipzgrgs5ioxulyydpeyj4

1 reference

https://api.fatcat.wiki/v0/release/nkfq2ipzgrgs5ioxulyydpeyj4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44480350&oldid=2025303054"